Selective stimulation of serotonin2Creceptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The effects of acute and repeated nicotine administration on the extracellular levels of dopamine (DA) in the corpus striatum and the nucleus accumbens were studied in conscious, freely moving rats by in vivo microdialysis. Acute intraperitoneal (i.p.) injection of nicotine (1 mg/kg) increased DA outflow both in the corpus striatum and the nucleus accumbens. Repeated daily injection of nicotine (1 mg/kg, i.p.) for 10 consecutive days caused a significant increase in basal DA outflow both in the corpus striatum and the nucleus accumbens. Acute challenge with nicotine (1 mg/kg, i.p.) in animals treated repeatedly with this drug enhanced DA extracellular levels in both brain areas. However, the effect of nicotine was potentiated in the nucleus accumbens, but not in the corpus striatum. To test the hypothesis that stimulation of 5‐HT (5‐hydroxytryptamine, serotonin)2C receptors could affect nicotine‐induced DA release, the selective 5‐HT 2C receptor agonist RO 60–0175 was used. Pretreatment with RO 60–0175 (1 and 3 mg/kg, i.p.) dose‐dependently prevented the enhancement in DA release elicited by acute nicotine in the corpus striatum, but was devoid of any significant effect in the nucleus accumbens. RO 60–0175 (1 and 3 mg/kg, i.p.) dose‐dependently reduced the stimulatory effect on striatal and accumbal DA release induced by an acute challenge with nicotine (1 mg/kg, i.p.) in rats treated repeatedly with this alkaloid. However, only the effect of 3 mg/kg RO 60–0175 reached statistical significance. The inhibitory effect of RO 60–0175 on DA release induced by nicotine in the corpus striatum and the nucleus accumbens was completely prevented by SB 242084 (0.5 mg/kg, i.p.) and SB 243213 (0.5 mg/kg, i.p.), two selective antagonists of 5‐HT 2C receptors. It is concluded that selective activation of 5‐HT 2C receptors can block the stimulatory action of nicotine on central DA function, an effect that might be relevant for the reported antiaddictive properties of RO 60–0175.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 1×
“In this respect, it is interesting to note that bupropion, which is an effective drug in the treatment of nicotine dependence (Jorenby et al. 1999), causes a sustained increase in the basal firing activity of 5-HT neurons in the DRN (Dong and Blier 2001).”
BackgroundIncentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · cited 2×
“…Olausson et al. 1999; Grottick et al. 2001; Iyaniwura et al. 2001; Shim et al. 2001; Schoffelmeer et al. 2002), a phenomenon known as sensitization which is common to psychostimulant drugs (Vanderschuren et al. 1999; White and Kalivas 1998; Robinson and Berridge 2001; Schoffelmeer et al. 2002).”
BackgroundPicciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · cited 1×
“…depolarize DA-containing neurons by activating somatodendritic nicotinic receptors which, in this region, are mostly constituted by the assembly of a4b2 subtypes (Calabresi et al. 1989; Pidoplichko et al. 1997; Picciotto et al. 1998; Sorenson et al. 1998; Klink et al. 2001; Mansvelder et al. 2002).”
BackgroundEffects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · cited 2×
“…in a number of studies showing that nicotine increases in vivo DA release in both brain areas (Imperato et al. 1986; Di Chiara and Imperato 1988; Damsma et al. 1989; Brazell et al. 1990; Toth et al. 1992; Nisell et al. 1994b; Pontieri et al. 1996; Maisonneuve et al. 1997; Marshall et al. 1997).”
BackgroundPhysiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · cited 3×
“However, some controversy about the relative contribution of each mechanisms on the overall effect of nicotine on DA release still exists (Corrigall et al. 1994; Nisell et al. 1994b).”
BackgroundResultLong-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701 · cited 2×
“…depolarize DA-containing neurons by activating somatodendritic nicotinic receptors which, in this region, are mostly constituted by the assembly of a4b2 subtypes (Calabresi et al. 1989; Pidoplichko et al. 1997; Picciotto et al. 1998; Sorenson et al. 1998; Klink et al. 2001; Mansvelder et al. 2002).”
Background
Cited by
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
5-HT Receptor Regulation of Neurotransmitter Release
Fink, K., & Göthert, M. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.07103 · Cited by 389
The current status of association studies in obsessive-compulsive disorder
Hemmings, S. M. J., & Stein, D. J. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.011 · Cited by 83
Zayara, A. E., McIver, G., Valdivia, P. N., Lominac, K. D., McCreary, A. C., & Szumlinski, K. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1996-3 · Cited by 64
Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain
Kane, J. K., Konu, Ö., Ma, J. Z., & Li, M. D. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.010 · Cited by 61
Metadata
- Authors
- Di Matteo, V., Pierucci, M., & Esposito, E.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-03-22
- Volume
- 89
- Issue
- 2
- Pages
- 418-429
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2008460092
- Cited by
- 76
- References
- 28
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective stimulation of serotonin2Creceptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. https://app.cochat.ai/papers/10.1111/j.1471-4159.2004.02337.x
- The paper
- Di Matteo, V., Pierucci, M., & Esposito, E. (2004). Selective stimulation of serotonin2Creceptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2004.02337.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.